Although CTLA-4 gene polymorphisms and sCTLA-4 have been investigated in autoimmune diseases and a few malignancies, their contribution to HCC development in the context of HCV infection remains poorly defined. Here, CTLA4 is linked to hepatocellular carcinoma.